FP7Reintegration grant2011–2015

CATABOLIC SIALIDASES · Understanding the roles of mammalian sialidases in glycolipid catabolism

FP7 — People (Marie Curie Actions)

Duration
2011-04-01 → 2015-03-31
EU contribution
€100,000
Participants
1
Scheme
MC-IRG

Lines connect the coordinator with its partners.

Results in brief

Understanding the roles of mammalian sialidases in glycolipid catabolism

Sialidases (neuraminidases) constitute a family of hydrolyses responsible for the removal of sialic acids from sialylated glycolipids, glycoproteins and oligosaccharides. Four mammalian sialidases have been cloned; a lysosomal form (Neu1), a cytosolic form (Neu2), a plasma membrane-associated form (Neu3) and a lysosomal/mitochondrial form (Neu4). Our goal has been to clarify biological functions of mammalian sialidase Neu1 in glycolipid degradation. We proposed to investigate the intralysosomal mechanism by which glycolipids are degraded by sialidase Neu1 and Neu4 as well as HexA using deficient mouse models. Therefore, the main objectives of our proposal are: (1) to generate Neu1-/- single knock-out mouse model (2) to generate HexA-/-Neu1-/- double knock-out mouse model (3) to generate Hexa-/-Neu1-/-Neu4-/- triple knockout mouse models. In order to generate Neu1-/- single gene knockout mouse model, embryonic stem (ES) cell were transfected with previously constructed Neu1 gene targetting vector (TV-Neu1-1) by electroporation. Although one positive clone among 110 screened colonies was obtained using different sets of 5’ and 3’ primer pairs outside of gene targeting region, S.blot analysis failed to confirm the correct gene targeting event in mouse Neu1 gene locus in that clone. Therefore, new Neu1 gene targeting vector (TV-Neu1-2) was constructed using similar strategy to achive our goal. New targeting vector were electroporated into ES cells to knockout mouse Neu1 sialidase gene by homologous recombination in ES cells. After double selection with geneticine and ganyclovir, this time we obtained 6 positive clones among 163 picked colonies and two of them were confirmed by S. Blot analysis. Positive clones were expanted and microinjected into blastocytes. Chimeric animals were received in September 2013. We observed chimerism between 10-90% as predicted. Chimeric females and males were crossed with C57B6 females and males. So far more than 592 pups were genotyped but no germline transmission were detected. Male chimerics although they are quide old are still in breeding with females and we keep genotyping their offsprings. In an parallel afford, we used our previously generated mice NeoIn-/- ( here named as Neu1-/-) with ~10% of normal sialidase Neu1 whick is likely to be suitable alternative model to test the role of sialidase Neu1 in metabolic bypass in HexA-/- mice (Seyrantepe et al, 2010, Larbi et al, 2013). Existing hypomorph mice strain Neu1-/- were breeded with HexA-/- mice model while generation of Neu1-/- full knockout mice in progress. Double knockout (HexA-/-Neu1-/-) and triple knockout (HexA-/-Neu1-/-Neu4-/-) mice strain were generated and brain ganglisoides were analyzed by thin layer chromatography. Altered ganglioside pattern were observed in double knock-out HexA-/-Neu1-/- as well as triple knockout (HexA-/-Neu1-/-Neu4-/- mice compared to single knock-out (HexA-/- , Neu4-/-, Neu1-/-) mice. We also performed biochemical (mass spectrometry), imminohistochemical and molecular biological analysis in brain tissue from those animals. Our manuscript showing our interesting results was accepted for publication in Mol Genet Met Reports (September 2015 issue)

Data: CORDIS, © European Union

Project objective

Sialidases are widely distributed in nature, from microorganisms to mammals. Mammalian sialidases differ in their tissue distribution, subcellular localization, substrate specificity and pH optimum. To date, several mammalian sialidases have been cloned; a lysosomal form (Neu1), a cytosolic form (Neu2), a plasma membrane-associated form (Neu3) and a lysosomal/mitochondrial form (Neu4). Defining the functional impact of sialidases on complex physiological and cellular processes should uncover the biological significance of sialidase-susceptible sialic acids on glycoproteins and glycolipids. Our goal has been to clarify biological functions of mammalian sialidases. Recently we investigated the role of lysosomal/mitochondrial sialidase Neu4 in glycolipid degradation using mouse model with the combined deficiency of β-hexosaminidase A (HexA) and sialidase Neu4. Our mouse model progressed toward the neuropathological abnormalities of human Tay-Sachs patients. The appearance of epileptic seizures and increased glycolipid storage demonstrated the predicted increased severity of disease indicative of the importance of Neu4 in glycolipid degradation but it is clear from the much milder than expected phenotype that other sialidases such as Neu1 and Neu3 also contribute to catabolism reactions. We now propose to investigate the intralysosomal mechanism by which glycolipids are degraded by sialidase Neu1 using mouse models. Therefore, the main objectives of this proposal are: (1) to generate first Neu1-/- knockout mouse models (2) to generate Neu1-/-HexA-/- (3) to generate Neu1-/-Neu4-/-HexA-/- triple knockout mouse models. If successful, our studies will significantly increase the state of knowledge of sialidase contribution in glycolipid degradation and can suggest new therapeutic approaches for Tay-Sachs disease based on the Neu1 and Neu4-catalyzed metabolic bypath.

Original text from CORDIS.

Participants

  • IZMIR INSTITUTE OF TECHNOLOGY · İzmirCoordinatorTürkiye

Links

Data: CORDIS, © European Union